Psychedelics and a Semi-Parallel Cannabis Universe
As psychedelic therapies continue to develop as contemplative businesses and in research programs commencing at both the state and federal levels in the United States, we are naturally compelled to learn from similar or semi-similar developments in the cannabis business regarding what has worked and what has not worked in addressing federally prohibited substances, their potential risks, potential benefits and
Rogoway Law Group
September 14, 2022